Here are three things to know.
- Protein Sciences is also eligible to receive up to $100 million in milestone payments.
- Through the acquisition, Sanofi will gain the rights to the flu vaccine Flublok. Unlike most vaccines grown in chicken eggs, Flublok is produced using a technology that rearranges genetic material to make the vaccine.
- The deal is expected to close in the third quarter of this year.
More articles on supply chain:
How Trump’s efforts to lower drug prices affect the industry — 4 questions on a possible executive order
Suburban Hospital wants to compete with MedStar Georgetown for liver transplants
Why supply chain leaders should practice unlearning
